KEYWORD

ophthalmology

Philip Kiser, UCI associate professor of physiology & biophysics as well as ophthalmology,

UC Irvine study shows similarities and differences in human and insect vision formation

Discovery offers insights into retinal disease origins and potential therapeutic targets

Baruch D. Kupperman, director of the Gavin Herbert Eye Institute

A decade of visionary achievement

UCI’s Gavin Herbert Eye Institute celebrates its 10th anniversary

Tibor Juhasz

Grabbing the Golden Goose

Tibor Juhasz honored for discovery that led to laser eye surgery

National Academy of Sciences names two UCI faculty members as fellows

Mathematician Svetlana Jitomirskaya, vision researcher Krzysztof Palczewski honored

Krzysztof “Kris” Palczewski

Vision visionary

UCI’s acclaimed Donald Bren Professor of Ophthalmology, Kris Palczewski, is blazing a trail of innovative research

The other March madness: Match Day

At festive ceremony, UCI medical students find out where they will start their careers as doctors

Krzysztof Palczewski, PhD, the Irving H. Leopold chair and a distinguished professor in the Gavin Herbert Eye Institute, Department of Ophthalmology at the UCI School of Medicine

UCI-led study reveals significant restoration of retinal and visual function following gene therapy

New generation CRISPR technology lays foundation for therapeutics to treat a wide range of inherited ocular diseases

Krzysztof Palczewski, UCI’s Irving H. Leopold Professor of Ophthalmology and a professor of physiology & biophysics

UCI vision scientist Krzysztof Palczewski elected to National Academy of Medicine

Distinction recognizes his contributions to understanding of retinal diseases

inventing-hero

Inventing a Better Future

From miniature beating hearts to hacker-resistant cellphones, UCI faculty, students and alumni have generated a multitude of remarkable inventions and discoveries.

Stem cell therapy for retinitis pigmentosa found safe, well-tolerated in first-stage clinical trial

Sue & Bill Gross Stem Cell Research Center researchers have reported that a therapy they created to cure retinitis pigmentosa is safe and well-tolerated, with no immunological issues, by the first group of patients enrolled in an ongoing phase I/II clinical trial. Led by the regenerative medicine company jCyte, the trial has successfully undergone four […]